Sectors & IndustriesHealthcareHealthcare Plans

Best Healthcare Plan Stocks to Buy Now (2024)

Top healthcare plan stocks in 2024 ranked by overall Due Diligence Score. See the best healthcare plan stocks to buy now, according to analyst forecasts for the healthcare plans industry.

According to Due Diligence Score, the 3 best healthcare plan stocks to buy right now are:

Molina Healthcare (NYSE:MOH) is the top healthcare plan stock with a Due Diligence Score of 59, which is 19 points higher than the healthcare plan industry average of 40. It passed 20 out of 33 due diligence checks and has strong fundamentals. Molina Healthcare has seen its stock lose -21.48% over the past year, underperforming other healthcare plan stocks by -1 percentage points.

Molina Healthcare has an average 1 year price target of $361.40, an upside of 21.61% from Molina Healthcare's current stock price of $297.18.

Molina Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Molina Healthcare, 40% have issued a Strong Buy rating, 10% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Elevance Health (NYSE:ELV) is the second best healthcare plan stock with a Due Diligence Score of 54, which is 14 points higher than the healthcare plan industry average of 40. It passed 19 out of 38 due diligence checks and has strong fundamentals. Elevance Health has seen its stock lose -21.74% over the past year, underperforming other healthcare plan stocks by -2 percentage points.

Elevance Health has an average 1 year price target of $519.91, an upside of 37.4% from Elevance Health's current stock price of $378.39.

Elevance Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Elevance Health, 72.73% have issued a Strong Buy rating, 18.18% have issued a Buy, 9.09% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Centene (NYSE:CNC) is the third best healthcare plan stock with a Due Diligence Score of 46, which is 6 points higher than the healthcare plan industry average of 40. It passed 15 out of 33 due diligence checks and has strong fundamentals. Centene has seen its stock lose -24.02% over the past year, underperforming other healthcare plan stocks by -4 percentage points.

Centene has an average 1 year price target of $82.92, an upside of 42.96% from Centene's current stock price of $58.00.

Centene stock has a consensus Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Centene, 41.67% have issued a Strong Buy rating, 16.67% have issued a Buy, 33.33% have issued a hold, while 8.33% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 5 healthcare plan stocks that have issued dividends in the past year, the 3 healthcare plan stocks with the highest dividend yields are:

Cvs Health (NYSE:CVS) has an annual dividend yield of 5.37%, which is 3 percentage points higher than the healthcare plan industry average of 2.39%. Cvs Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cvs Health's dividend has shown consistent growth over the last 10 years.

Cvs Health's dividend payout ratio of 67.3% indicates that its high dividend yield is sustainable for the long-term.

Cigna Group (NYSE:CI) has an annual dividend yield of 1.98%, which is the same as the healthcare plan industry average of 2.39%. Cigna Group's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cigna Group's dividend has shown consistent growth over the last 10 years.

Cigna Group's dividend payout ratio of 50.6% indicates that its dividend yield is sustainable for the long-term.

Elevance Health (NYSE:ELV) has an annual dividend yield of 1.72%, which is -1 percentage points lower than the healthcare plan industry average of 2.39%. Elevance Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Elevance Health's dividend has shown consistent growth over the last 10 years.

Elevance Health's dividend payout ratio of 23.1% indicates that its dividend yield is sustainable for the long-term.

Healthcare plan stocks were down -2.43% in the last day, and down -7.06% over the last week. Cvs Health was the among the top losers in the healthcare plans industry, dropping -4.21% yesterday.

Shares of pharmacy benefit manager stocks are trading lower in possible reaction to a recent report suggesting a bipartisan lawmakers are seeking to potentially break up companies in the sector.

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare plan stocks right now are:

Cvs Health (NYSE:CVS) is the most undervalued healthcare plan stock based on WallStreetZen's Valuation Score. Cvs Health has a valuation score of 71, which is 42 points higher than the healthcare plan industry average of 29. It passed 5 out of 7 valuation due diligence checks.

Cvs Health's stock has dropped -32.63% in the past year. It has underperformed other stocks in the healthcare plan industry by -13 percentage points.

Centene (NYSE:CNC) is the second most undervalued healthcare plan stock based on WallStreetZen's Valuation Score. Centene has a valuation score of 57, which is 28 points higher than the healthcare plan industry average of 29. It passed 4 out of 7 valuation due diligence checks.

Centene's stock has dropped -24.02% in the past year. It has underperformed other stocks in the healthcare plan industry by -4 percentage points.

Elevance Health (NYSE:ELV) is the third most undervalued healthcare plan stock based on WallStreetZen's Valuation Score. Elevance Health has a valuation score of 57, which is 28 points higher than the healthcare plan industry average of 29. It passed 4 out of 7 valuation due diligence checks.

Elevance Health's stock has dropped -21.74% in the past year. It has underperformed other stocks in the healthcare plan industry by -2 percentage points.